Biologic or biosimilar: What are prescribers thinking? - PME

Why does biosimilar adoption vary, even with significant discounts? What factors beyond price are encouraging or deterring biosimilar usage? And how do these factors affect the ultimate choice of a biologic vs biosimilar?

Published on the Pharmaceutical Market Europe (PME) December 2017 issue, our senior research manager, Adriënne discussed what prescribers are thinking when deciding between biologic vs biosimilar.